Elevation Oncology, Inc.
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-…
Biotechnology
US, New York [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Elevation Oncology, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDElevation Oncology, Inc. can't present revenue by segment